Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

4.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

24.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
MicroRNAs01:22

MicroRNAs

12.1K
12.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations for the management of septic arthritis after ACL reconstruction.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2013
Same author

Poly(ADP-ribose) polymerase 1 promotes oxidative-stress-induced liver cell death via suppressing farnesoid X receptor α.

Molecular and cellular biology·2013
Same author

[Clinical significance of changes in T wave and ST segment amplitudes on electrocardiogram from supine to standing position among children with unexplained chest tightness or pain in resting stage].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2013
Same author

Biomimetic synthesis of equisetin and (+)-fusarisetin A.

Chemistry (Weinheim an der Bergstrasse, Germany)·2013
Same author

ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer.

ISRN urology·2013
Same author

Syphilis screening among 27,150 pregnant women in South Chinese rural areas using point-of-care tests.

PloS one·2013

Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

2.6K

MicroRNAs in osteosarcoma.

Jian Zhang1, Yi-Guo Yan1, Cheng Wang1

  • 1Department of Spine Surgery, The First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|February 10, 2015
PubMed
Summary

Osteosarcoma (OS) treatment needs new approaches due to chemotherapy resistance. MicroRNAs (miRNAs) show promise as therapeutic targets and biomarkers for this bone cancer.

Keywords:
ChemoresistanceNotchOSTP53miRNAs

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K
MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

452

Related Experiment Videos

Last Updated: Apr 17, 2026

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

2.6K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K
MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

452

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma (OS) is a primary bone cancer primarily affecting children and adolescents, with poor prognosis linked to chemotherapy resistance.
  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression, implicated in various cancers, including OS.
  • Differential expression of miRNAs in OS tissues and serum suggests their role as oncogenes or tumor suppressors.

Purpose of the Study:

  • To review miRNA biochemistry, focusing on their expression profiles, roles in osteosarcoma development, and therapeutic potential.
  • To highlight the significance of understanding miRNA alterations for identifying novel biomarkers.
  • To explore the development of miRNA-targeted therapies for osteosarcoma.

Main Methods:

  • Literature review of miRNA biochemistry and function in osteosarcoma.
  • Analysis of miRNA expression profiles in OS tissues, cell lines, and serum.
  • Evaluation of the therapeutic potential of miRNA restoration in OS models.

Main Results:

  • miRNAs are differentially expressed in OS and influence tumorigenesis.
  • Altered miRNAs can act as oncogenes or tumor suppressors in osteosarcoma.
  • Restoring miRNA expression demonstrates therapeutic promise for OS treatment.

Conclusions:

  • Understanding miRNA expression and function is crucial for osteosarcoma research.
  • miRNAs hold potential as diagnostic biomarkers and therapeutic targets for osteosarcoma.
  • miRNA-targeted therapies represent a promising avenue for improving OS patient outcomes.